<DOC>
	<DOCNO>NCT02706977</DOCNO>
	<brief_summary>The purpose study evaluate use electroretinogram ( ERG ) use novel handheld system , RETeval , evaluate contrast sensitivity test detect pre-clinical retinopathy tablet device . Investigators also seek assess medication call Sinemet™ CR improve electrical function eye participant diabetes mellitus . This study include total 45 participant ; 30 diabetes mellitus 15 age-matched non-diabetic control . Participants diabetes mellitus electroretinogram ( ERG ) delay randomize low high dose Sinemet CR group .</brief_summary>
	<brief_title>The Effect Dopamine Diabetic Retinopathy</brief_title>
	<detailed_description>The purpose study evaluate use electroretinogram ( ERG ) use novel handheld system , RETeval , evaluate contrast sensitivity test detect pre-clinical retinopathy tablet device . Investigators also seek assess medication call Sinemet™ CR improve electrical function eye participant diabetes mellitus . This study include total 45 participant ; 30 diabetes mellitus 15 age-matched non-diabetic control . Participants diabetes mellitus electroretinogram ( ERG ) delay randomize low high dose Sinemet™ CT group . Age-matched control receive Sinemet Ct drug treatment . The study involve four visit course 4 week , visit consist 2-3 hour . Visual testing perform 1 day 2 week follow treatment . The drug treatment halt test repeat 2 week wash-out period .</detailed_description>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>Inclusion Criteria Participants Diabetes Mellitus : Diagnosis diabetes mellitus type2 HbA1c 8 12 % AgeMatched Controls : Nondiabetic Exclusion Criteria Participants Diabetes Mellitus : Currently take dopamineenhancing drug ( LDOPA , bromocriptine ) Currently take nonselective monoamine oxidase ( MAO ) inhibitor Diagnosis psychosis , Parkinson 's disease , restless leg syndrome , major depression , confound ocular disease ( eg . visually significant cataract , glaucoma , macular degeneration , retinitis pigmentosa ) Pregnancy AgeMatched Controls : Diabetes diagnosis Currently take dopamineenhancing drug ( LDOPA , bromocriptine ) Currently take nonselective monoamine oxidase ( MAO ) inhibitor Diagnosis psychosis , Parkinson 's disease , restless leg syndrome , major depression , confound ocular disease ( eg . visually significant cataract , glaucoma , macular degeneration , retinitis pigmentosa ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Ophthalmology</keyword>
</DOC>